Medicare Enrolled
Dr. Babak Zamiri, M.D.
Optician · Riverside, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zamiri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zamiri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zamiri
Dr. Babak Zamiri is an optician specialist in Riverside, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zamiri performed 28,528 Medicare services across 1,840 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zamiri received a total of $9,654 from 31 pharmaceutical and/or device companies across 449 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zamiri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in CA
$9,654 industry payments
Medicare Practice Summary
Medicare Utilization ↗28,528
Medicare services
Top 4% in CA for optician
1,840
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,426 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 10,297 | $8 | $15 |
| Denosumab injection (Prolia/Xgeva) | 7,765 | $18 | $40 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
6,407 | $26 | $149 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
785 | $95 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
310 | $11 | $40 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
297 | $13 | $60 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
269 | $24 | $166 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
267 | $112 | $301 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 236 | $14 | $40 |
| Injection, methylprednisolone acetate, 40 mg | 231 | $6 | $20 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
205 | $1 | $10 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
179 | $59 | $300 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
160 | $63 | $160 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
153 | $115 | $160 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
142 | $9 | $20 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
138 | $63 | $125 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
135 | $17 | $40 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
133 | $41 | $240 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
93 | $53 | $100 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
76 | $4 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
74 | $134 | $225 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
43 | $6 | $233 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $126 | $300 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
29 | $59 | $125 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
21 | $49 | $100 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
18 | $4 | $40 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
16 | $46 | $112 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
11 | $69 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.7% high complexity
72.2% medium
4.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,654
Total received (2018-2024)
Avg $1,379/year across 7 years
Top 14% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
449
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,652 (89.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$840 (8.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$161 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,397
2023
$1,547
2022
$1,126
2021
$1,006
2020
$1,023
2019
$2,000
2018
$1,555
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$407
Novartis Pharmaceuticals Corporation
$236
US Oncology Corporate, Inc.
$192
GlaxoSmithKline, LLC.
$108
E.R. Squibb & Sons, L.L.C.
$68
UCB, Inc.
$63
Aurinia Pharma U.S., Inc.
$63
Janssen Biotech, Inc.
$60
Radius Health, Inc.
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
DePuy Synthes Sales Inc.
$26
Lilly USA, LLC
$24
ABBVIE INC.
$22
PFIZER INC.
$16
SCILEX PHARMACEUTICALS INC.
$15
Top 3 companies account for 59.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,046
Amgen Inc.
$1,861
Horizon Therapeutics plc
$821
AbbVie, Inc.
$770
Novartis Pharmaceuticals Corporation
$613
GlaxoSmithKline, LLC.
$462
UCB, Inc.
$442
Lilly USA, LLC
$324
AbbVie Inc.
$320
Janssen Scientific Affairs, LLC
$229
Aurinia Pharma U.S., Inc.
$208
E.R. Squibb & Sons, L.L.C.
$201
US Oncology Corporate, Inc.
$192
Genentech USA, Inc.
$181
AstraZeneca Pharmaceuticals LP
$164
PFIZER INC.
$159
GENZYME CORPORATION
$127
Radius Health, Inc.
$65
Mallinckrodt Hospital Products Inc.
$52
Horizon Pharma plc
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Mallinckrodt Enterprises LLC
$45
NOVARTIS PHARMACEUTICALS CORPORATION
$44
Mallinckrodt LLC
$42
Celgene Corporation
$42
SANOFI-AVENTIS U.S. LLC
$38
Merck Sharp & Dohme Corporation
$33
DePuy Synthes Sales Inc.
$26
ABBVIE INC.
$22
SCILEX PHARMACEUTICALS INC.
$15
Ironwood Pharmaceuticals, Inc
$11
Top 3 companies account for 49.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · BENLYSTA · Bimzelx · CHANTIX · COSENTYX · Cimzia · DUZALLO · EVENITY · Enbrel · FASENRA · HUMIRA · Humira · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · NUCALA · OFEV · ORENCIA · Otezla · PENNSAID · RAYOS · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TEPEZZA · TREMFYA · Tavneos · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
250
Per 100K population
10.2
County median income
$89,672
Nearest hospital
PACIFIC GROVE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zamiri is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zamiri experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Zamiri performed 10,297 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zamiri receive payments from pharmaceutical companies?
Yes. Dr. Zamiri received a total of $9,654 from 31 companies across 449 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zamiri's costs compare to other opticians in Riverside?
Dr. Zamiri's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zamiri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Riverside
Browse opticians in Riverside ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology